Industry News

22/05/2024

Pharmas are upping spending on digital, but still face budgetary blocks.

Perhaps a major reason for the smaller-than-needed budgets is a disconnect between digital-focused teams and upper management in terms of how success is measured: Almost two-thirds of those surveyed said the digital metrics they’re tracking don’t align with their companies’ larger strategic KPIs.

22/05/2024

Merck KGaA makes $600M bet to boost manufacturing for viral vectors.

Merck KGaA announced Wednesday that it is acquiring Mirus Bio, a startup that develops transfection reagents for viral cell and gene therapies, for $600 million.

21/05/2024

ADC biotech Pheon raises $120M to test three assets in the clinic.

Pheon Therapeutics is the latest to catch the tailwinds of the booming segment of oncology R&D. The London-based startup disclosed a $120 million Series B Tuesday morning from lead investor TCGX.

Connect with us, and see what’s new at Lucivio Partners.

Follow us on LinkedIn to stay updated on insights and opportunities.